Hindustan Herbals Profile
Key Indicators
- Authorised Capital ₹ 36.00 Cr
as on 16-01-2025
- Paid Up Capital ₹ 15.03 Cr
as on 16-01-2025
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 28.60 Cr
as on 16-01-2025
- Revenue 146.80%
(FY 2019)
- Profit -16.21%
(FY 2019)
- Ebitda 30.06%
(FY 2019)
- Net Worth -28.05%
(FY 2019)
- Total Assets 14.59%
(FY 2019)
About Hindustan Herbals
- CIN/LLPIN
U01400DL2010PLC372430
- Company No.
040010
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Jan 2010
- Date of AGM
23 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Hindustan Herbals Limited offer?
Hindustan Herbals Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API (Active Pharmaceutical Ingredients), Ayurvedic & Herbal Extracts, Anti Bacterial & Fungal Extracts, Herbal Powder, Garcinia Cambogia Extract Powder, Turmeric Products, Turmeric Curcumin, Herbs,Sticks and Roots, Coleus Forskohlii.
Who are the key members and board of directors at Hindustan Herbals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raman Bhatti  | Company Secretary | 13-Feb-2017 | Current |
| Rashmi Bhatia | CFO | 09-Oct-2020 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikram Grover | Director | 27-May-2020 | Current |
| Ashish Kumar | Director | 27-May-2020 | Current |
| Akhilesh Tripathi | Whole-Time Director | 27-May-2020 | Current |
Financial Performance of Hindustan Herbals.
Hindustan Herbals Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 146.8% increase. The company also saw a substantial fall in profitability, with a 16.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hindustan Herbals?
In 2019, Hindustan Herbals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tata Capital Financial Services Limited Creation Date: 24 May 2018 | ₹5.00 Cr | Satisfied |
Others Creation Date: 11 Apr 2017 | ₹10.00 Cr | Satisfied |
Bank Of Maharshtra Creation Date: 07 Sep 2010 | ₹13.60 Cr | Satisfied |
How Many Employees Work at Hindustan Herbals?
Unlock and access historical data on people associated with Hindustan Herbals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hindustan Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hindustan Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
